Global and United States Congestive Heart Failure (CHF) Treatment Devices Market Growth 2015-2025

Publisher Name :
Date: 20-Nov-2020
No. of pages: 99

This study researches the Congestive Heart Failure (CHF) Treatment Devices market overview in global and United States market.

For the global market, this report focuses on the market size of Congestive Heart Failure (CHF) Treatment Devices in global, regional and country-level market, by regions (countries), by Type, and by Application, for the period 2015-2025. It also includes the Congestive Heart Failure (CHF) Treatment Devices provides details and data information by players for the period 2015-2020.

For United States market, the report presents the markets size of Congestive Heart Failure (CHF) Treatment Devices by Type, and by Application for the period 2015-2026. It also provides the Congestive Heart Failure (CHF) Treatment Devices sales and revenue by players for the period 2015-2020.

According to this study, over the next five years the Congestive Heart Failure (CHF) Treatment Devices market will register a 3.2%% CAGR in terms of revenue, the global market size will reach $ 5523.1 million by 2025, from $ 4862.6 million in 2019. In particular, this report presents the global revenue market share of key companies in Congestive Heart Failure (CHF) Treatment Devices business, shared in Chapter 3.

Segmentation by Type:

- Cardiac Resynchronization Therapy (CRT)

- Implantable Cardioverter Defibrillators (ICDs)

Segmentation by Application

- Left Ventricular Assist Device (LVAD)

- Right Ventricular Assist Device (RVAD)

- Biventricular Assist Device (BIVAD)

This report also splits the market by region:

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Spain

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.

- Abiomed

- Abbott

- Berlin Heart GmbH

- Boston Scientific Corporation

- HeartWare International

- Biotronik SE & Co. KG

- Medtronic

- Jarvik Heart

- ReliantHeart

- LivaNova PLC

Global and United States Congestive Heart Failure (CHF) Treatment Devices Market Growth 2015-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size and Forecast 2015-2025
2.1.2 Congestive Heart Failure (CHF) Treatment Devices Market Size and Forecast by Region (2015-2025)
2.2 United States Market Overview
2.2.1 United States Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth, 2015-2025 (K Units)
2.2.2 United States Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth, 2015-2025 ($ millions)

3 Congestive Heart Failure (CHF) Treatment Devices Segment by Type
3.1 Overview
3.1.1 Cardiac Resynchronization Therapy (CRT)
3.1.2 Implantable Cardioverter Defibrillators (ICDs)
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type, 2015-2020
3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type, 2015-2020 (K Units) ($ millions)
3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Type, 2020-2020
3.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Type, 2020-2025
3.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Type, 2020-2025 (K Units) ($ millions)
3.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Type, 2020-2025
3.4 United States Congestive Heart Failure (CHF) Treatment Devices Market Size by Type, 2015-2025
3.4.1 Congestive Heart Failure (CHF) Treatment Devices Market Size in United States by Type, 2015-2020 (K Units)
3.4.2 Congestive Heart Failure (CHF) Treatment Devices Market Size in United States by Type, 2015-2020 ($ millions)
3.4.3 United States Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Type, 2020-2025 ($ millions)

4 Congestive Heart Failure (CHF) Treatment Devices Segment by Application
4.1 Overview
4.1.1 Left Ventricular Assist Device (LVAD)
4.1.2 Right Ventricular Assist Device (RVAD)
4.1.3 Biventricular Assist Device (BIVAD)
4.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application, 2015-2020
4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application, 2015-2020 (K Units) ($ millions)
4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Application, 2020-2020
4.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application, 2020-2025
4.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application, 2020-2020 (K Units) ($ millions)
4.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Application, 2020-2025
4.4 United States Congestive Heart Failure (CHF) Treatment Devices Market Size by Application, 2015-2025
4.4.1 Congestive Heart Failure (CHF) Treatment Devices Market Size in United States by Application, 2015-2020 (K Units)
4.4.2 Congestive Heart Failure (CHF) Treatment Devices Market Size in United States by Application, 2015-2020 ($ millions)
4.4.3 United States Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application, 2020-2025 ($ millions)

5 Vendor Landscape
5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Players
5.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Players, (2018-2020)
5.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Players, (2018-2020)
5.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Players
5.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Players, (2018-2020)
5.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Players, (2018-2020)
5.3 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Players
5.4 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Producing Area Distribution, Sales Area, Product Type
5.4.1 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Location Distribution
5.4.2 Players Congestive Heart Failure (CHF) Treatment Devices Products Offered
5.5 Market Concentration Rate Analysis
5.5.1 Competition Landscape Analysis
5.5.2 Concentration Ratio (CR3, CR5 and CR10), (2018-2020)
5.6 New Products and Potential Entrants
5.7 Mergers & Acquisitions, Expansion

6 United States Market Size by Players
6.1 Key Players Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in United States, 2018-2020
6.1.1 Key Players Congestive Heart Failure (CHF) Treatment Devices Sales in United States, 2018-2020 (K Units)
6.1.2 Key Players Congestive Heart Failure (CHF) Treatment Devices Sales Market Share in United States, (2018-2020)
6.2 United States Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Players
6.2.1 United States Congestive Heart Failure (CHF) Treatment Devices Revenue by Players, (2018-2020) ($ millions)
6.2.2 Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share in United States, by Players, (2018-2020)

7 Global Congestive Heart Failure (CHF) Treatment Devices by Regions
7.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region, 2015-2020
7.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region, 2015-2020 (K Units)
7.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region, 2015-2020 ($ millions)
7.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Region, 2020-2025
7.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Region, 2020-2025
7.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Region, 2020-2025 ($ millions)
7.3 Americas Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth, 2015-2025 ($ millions)
7.4 APAC Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth, 2015-2025 ($ millions)
7.5 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth, 2015-2025 ($ millions)
7.6 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth, 2015-2025 ($ millions)

8 Americas
8.1 Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Country
8.1.1 Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2015-2020)
8.1.2 Americas Congestive Heart Failure (CHF) Treatment Devices Value by Country (2015-2020)
8.2 Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020)
8.3 Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Application (2015-2020)
8.4 United States
8.5 Canada
8.6 Mexico
8.7 Brazil

9 APAC
9.1 APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Country
9.1.1 APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2015-2020)
9.1.2 APAC Congestive Heart Failure (CHF) Treatment Devices Value by Country (2015-2020)
9.2 APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2015-2020)
9.3 APAC Congestive Heart Failure (CHF) Treatment Devices Value by Country (2015-2020)
9.4 China
9.5 Japan
9.6 Korea
9.7 Southeast Asia
9.8 India
9.9 Australia

10 Europe
10.1 Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Country
9.1.1 Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2015-2020)
9.1.2 Europe Congestive Heart Failure (CHF) Treatment Devices Value by Country (2015-2020)
10.2 Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2015-2020)
10.3 Europe Congestive Heart Failure (CHF) Treatment Devices Value by Country (2015-2020)
10.4 Germany
10.5 France
10.6 UK
10.7 Italy
10.8 Russia
10.9 Spain

11 Middle East & Africa
11.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Country
11.1.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2015-2020)
11.1.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Value by Country (2015-2020)
11.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2015-2020)
11.3 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Value by Country (2015-2020)
11.4 Egypt
11.5 South Africa
11.6 Israel
11.7 Turkey
11.8 GCC Countries

12 Market Drivers, Challenges and Trends
12.1 Market Drivers and Impact
12.1.1 Growing Demand from Key Regions
12.1.2 Growing Demand from Key Applications and Potential Industries
12.2 Market Challenges and Impact
12.3 Market Trends

13 Marketing, Distributors and Customer
13.1 Sales Channel
13.1.1 Direct Channels
13.1.2 Indirect Channels
13.2 Congestive Heart Failure (CHF) Treatment Devices Distributors
13.3 Congestive Heart Failure (CHF) Treatment Devices Customer

14 Key Players Analysis
14.1 Abiomed
14.1.1 Abiomed Company Information
14.1.2 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Offered
14.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
14.1.4 Abiomed Main Business Overview
14.1.5 Abiomed Latest Developments
14.2 Abbott
14.2.1 Abbott Company Information
14.2.2 Abbott Congestive Heart Failure (CHF) Treatment Devices Product Offered
14.2.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
14.2.4 Abbott Main Business Overview
14.2.5 Abbott Latest Developments
14.3 Berlin Heart GmbH
14.3.1 Berlin Heart GmbH Company Information
14.3.2 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Offered
14.3.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
14.3.4 Berlin Heart GmbH Main Business Overview
14.3.5 Berlin Heart GmbH Latest Developments
14.4 Boston Scientific Corporation
14.4.1 Boston Scientific Corporation Company Information
14.4.2 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Offered
14.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
14.4.4 Boston Scientific Corporation Main Business Overview
14.4.5 Boston Scientific Corporation Latest Developments
14.5 HeartWare International
14.5.1 HeartWare International Company Information
14.5.2 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Offered
14.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
14.5.4 HeartWare International Main Business Overview
14.5.5 HeartWare International Latest Developments
14.6 Biotronik SE & Co. KG
14.6.1 Biotronik SE & Co. KG Company Information
14.6.2 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Offered
14.6.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
14.6.4 Biotronik SE & Co. KG Main Business Overview
14.6.5 Biotronik SE & Co. KG Latest Developments
14.7 Medtronic
14.7.1 Medtronic Company Information
14.7.2 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Offered
14.7.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
14.7.4 Medtronic Main Business Overview
14.7.5 Medtronic Latest Developments
14.8 Jarvik Heart
14.8.1 Jarvik Heart Company Information
14.8.2 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Offered
14.8.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
14.8.4 Jarvik Heart Main Business Overview
14.8.5 Jarvik Heart Latest Developments
14.9 ReliantHeart
14.9.1 ReliantHeart Company Information
14.9.2 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Offered
14.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
14.9.4 ReliantHeart Main Business Overview
14.9.5 ReliantHeart Latest Developments
14.10 LivaNova PLC
14.10.1 LivaNova PLC Company Information
14.10.2 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Offered
14.10.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
14.10.4 LivaNova PLC Main Business Overview
14.10.5 LivaNova PLC Latest Developments

15 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Congestive Heart Failure (CHF) Treatment Devices Consumption CAGR by Region (2015-2025) ($ millions)
Table 4. Major Players of Cardiac Resynchronization Therapy (CRT)
Table 5. Major Players of Implantable Cardioverter Defibrillators (ICDs)
Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Consumption by Type, 2015-2020 (K Units)
Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type, 2015-2025 ($ millions)
Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type, 2015-2025
Table 9. Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Type, 2015-2020
Table 10. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast by Type, 2020-2025 (K Units)
Table 11. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Type, 2020-2025 ($ millions)
Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Share Forecast by Type, 2020-2025
Table 13. United States Congestive Heart Failure (CHF) Treatment Devices Market Size by Type, 2015-2020 ($ millions)
Table 14. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type, 2015-2020
Table 15. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Type, 2020-2025 ($ millions)
Table 16. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Share Forecast by Type, 2020-2025
Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application, 2015-2020 (K Units)
Table 18. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application, 2015-2020 ($ million)
Table 19. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Application, 2015-2020
Table 20. Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Application, 2015-2020
Table 21. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application, 2020-2025 (K Units)
Table 22. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application, 2020-2025 ($ million)
Table 23. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Application, 2020-2025
Table 24. Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Application, 2020-2025
Table 25. United States Congestive Heart Failure (CHF) Treatment Devices Market Size by Application, 2015-2020 ($ millions)
Table 26. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Application, 2015-2020
Table 27. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application, 2020-2025 ($ millions)
Table 28. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Share Forecast by Application, 2020-2025
Table 29. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Player, 2018-2020E ($ millions)
Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Player, 2018-2020E
Table 31. Key Players Congestive Heart Failure (CHF) Treatment Devices Revenue in United States (2018-2020E) ($ millions)
Table 32. Key Players Congestive Heart Failure (CHF) Treatment Devices Market Share in United States (2018-2020E)
Table 33. Congestive Heart Failure (CHF) Treatment Devices Key Players Head office and Products Offered
Table 34. Congestive Heart Failure (CHF) Treatment Devices Concentration Ratio (CR3, CR5 and CR10), 2018-2020E
Table 35. New Products and Potential Entrants
Table 36. Mergers & Acquisitions, Expansion
Table 37. Global Congestive Heart Failure (CHF) Treatment Devices Consumption by Region, 2015-2020 (K Units)
Table 38. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Share by Region, 2015-2020
Table 39. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Regions, 2015-2025 ($ millions)
Table 40. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Regions, 2015-2025
Table 41. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Regions, 2020-2025 ($ millions)
Table 42. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Share Forecast by Regions, 2020-2025
Table 43. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Region, 2020-2025
Table 44. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2015-2020) (K Units)
Table 45. Americas Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Country (2015-2020)
Table 46. Americas Congestive Heart Failure (CHF) Treatment Devices Market Value by Country (2015-2020) ($ millions)
Table 47. Americas Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Country (2015-2020)
Table 48. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 49. Americas Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type (2015-2020)
Table 50. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 51. Americas Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type (2015-2020)
Table 52. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2015-2020) (K Units)
Table 53. APAC Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Country (2015-2020)
Table 54. APAC Congestive Heart Failure (CHF) Treatment Devices Market Value by Country (2015-2020) ($ millions)
Table 55. APAC Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Country (2015-2020)
Table 56. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 57. APAC Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type (2015-2020)
Table 58. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 59. APAC Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type (2015-2020)
Table 60. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2015-2020) (K Units)
Table 61. Europe Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Country (2015-2020)
Table 62. Europe Congestive Heart Failure (CHF) Treatment Devices Market Value by Country (2015-2020) ($ millions)
Table 63. Europe Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Country (2015-2020)
Table 64. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 65. Europe Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type (2015-2020)
Table 66. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 67. Europe Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type (2015-2020)
Table 68. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Country (2015-2020) (K Units)
Table 69. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Country (2015-2020)
Table 70. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Market Value by Country (2015-2020) ($ millions)
Table 71. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Country (2015-2020)
Table 72. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 73. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type (2015-2020)
Table 74. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 75. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type (2015-2020)
Table 76. Key and Potential Regions of Congestive Heart Failure (CHF) Treatment Devices
Table 77. Key Application and Potential Industries of Congestive Heart Failure (CHF) Treatment Devices
Table 78. Key Challenges of Congestive Heart Failure (CHF) Treatment Devices
Table 79. Key Trends of Congestive Heart Failure (CHF) Treatment Devices
Table 80. Congestive Heart Failure (CHF) Treatment Devices Distributors List
Table 81. Congestive Heart Failure (CHF) Treatment Devices Customer List
Table 82. Abiomed Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 83. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Offered
Table 84. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 85. Abiomed Main Business
Table 86. Abiomed Latest Developments
Table 87. Abbott Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 88. Abbott Congestive Heart Failure (CHF) Treatment Devices Product Offered
Table 89. Abbott Main Business
Table 90. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Abbott Latest Developments
Table 92. Berlin Heart GmbH Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 93. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Offered
Table 94. Berlin Heart GmbH Main Business
Table 95. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Berlin Heart GmbH Latest Developments
Table 97. Boston Scientific Corporation Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 98. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Offered
Table 99. Boston Scientific Corporation Main Business
Table 100. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Boston Scientific Corporation Latest Developments
Table 102. HeartWare International Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 103. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Offered
Table 104. HeartWare International Main Business
Table 105. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 106. HeartWare International Latest Developments
Table 107. Biotronik SE & Co. KG Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 108. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Offered
Table 109. Biotronik SE & Co. KG Main Business
Table 110. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Biotronik SE & Co. KG Latest Developments
Table 112. Medtronic Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 113. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Offered
Table 114. Medtronic Main Business
Table 115. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Medtronic Latest Developments
Table 117. Jarvik Heart Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 118. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Offered
Table 119. Jarvik Heart Main Business
Table 120. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. Jarvik Heart Latest Developments
Table 122. ReliantHeart Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 123. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Offered
Table 124. ReliantHeart Main Business
Table 125. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. ReliantHeart Latest Developments
Table 127. LivaNova PLC Details, Company Total Revenue (in $ million), Head Office, Congestive Heart Failure (CHF) Treatment Devices Major Market Areas and Its Competitors
Table 128. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Offered
Table 129. LivaNova PLC Main Business
Table 130. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. LivaNova PLC Latest Developments

List of Figures

Figure 1. Picture of Congestive Heart Failure (CHF) Treatment Devices
Figure 2. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered
Figure 3. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Year-over-Year Growth 2015-2025 (K Units)
Figure 4. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Year-over-Year Growth 2015-2025 ($ millions)
Figure 5. Congestive Heart Failure (CHF) Treatment Devices Consumption by Region (2020 & 2025) ($ millions)
Figure 6. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Year-over-Year Growth 2015-2025 (K Units)
Figure 7. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Year-over-Year Growth 2015-2025 ($ millions)
Figure 8. Product Picture of Cardiac Resynchronization Therapy (CRT)
Figure 9. Product Picture of Implantable Cardioverter Defibrillators (ICDs)
Figure 10. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Type, 2015-2020
Figure 11. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type in 2019
Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Type, 2020-2025
Figure 13. United States Congestive Heart Failure (CHF) Treatment Devices Consumption by Type, 2015-2020 (K Units)
Figure 14. United States Congestive Heart Failure (CHF) Treatment Devices Market Size by Type, 2015-2020 ($ million)
Figure 15. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Type, 2020-2025 (K Units)
Figure 16. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Type, 2020-2025 ($ million)
Figure 17. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Type, 2020-2025
Figure 18. United States Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Type, 2020-2025
Figure 19. Congestive Heart Failure (CHF) Treatment Devices Consumed in Left Ventricular Assist Device (LVAD)
Figure 20. Global Congestive Heart Failure (CHF) Treatment Devices Market Size: Left Ventricular Assist Device (LVAD), 2015-2025 (K Units)
Figure 21. Congestive Heart Failure (CHF) Treatment Devices Consumed in Right Ventricular Assist Device (RVAD)
Figure 22. Global Congestive Heart Failure (CHF) Treatment Devices Market Size: Right Ventricular Assist Device (RVAD), 2015-2025 (K Units)
Figure 23. Congestive Heart Failure (CHF) Treatment Devices Consumed in Biventricular Assist Device (BIVAD)
Figure 24. Global Congestive Heart Failure (CHF) Treatment Devices Market Size: Biventricular Assist Device (BIVAD), 2015-2025 (K Units)
Figure 25. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Application, 2015-2020
Figure 26. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Application in 2019
Figure 27. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Application, 2020-2025
Figure 28. United States Congestive Heart Failure (CHF) Treatment Devices Market Size by Application, 2015-2020 (K Units)
Figure 29. United States Congestive Heart Failure (CHF) Treatment Devices Market Size by Application, 2015-2020 ($ million)
Figure 30. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application, 2020-2025 (K Units)
Figure 31. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application, 2020-2025 ($ million)
Figure 32. United States Congestive Heart Failure (CHF) Treatment Devices Market Size Share by Application, 2020-2025
Figure 33. United States Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Application, 2020-2025
Figure 34. Congestive Heart Failure (CHF) Treatment Devices Sales by Players in 2019 (K Units)
Figure 35. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Players in 2019
Figure 36. Congestive Heart Failure (CHF) Treatment Devices Revenue by Players in 2019 ($ millions)
Figure 37. Global
  • Global and Japan Ovarian Cancer Diagnostics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 159
    Global Ovarian Cancer Diagnostics Scope and Market Size Ovarian Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ovarian Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the ......
  • Global and Japan Non-Invasive Cancer Diagnostics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 92
    Global Non-Invasive Cancer Diagnostics Scope and Market Size Non-Invasive Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-Invasive Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segmen......
  • Global and China Diabetes Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 155
    Global Diabetes Therapeutics and Diagnostics Scope and Market Size Diabetes Therapeutics and Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. ......
  • Global and United States Circulating Tumor Cell Diagnostics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 127
    Global Circulating Tumor Cell Diagnostics Scope and Market Size Circulating Tumor Cell Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Mark......
  • Global and China Alzheimer's Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 98
    Global Alzheimer's Disease Therapeutics and Diagnostics Scope and Market Size Alzheimer's Disease Therapeutics and Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for......
  • Global and Japan Myocardial Infarction Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 99
    Global Myocardial Infarction Therapeutics Scope and Market Size Myocardial Infarction Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Myocardial Infarction Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Mark......
  • Global and China Angioedema Treatment Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 90
    Global Angioedema Treatment Scope and Market Size Angioedema Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Angioedema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be spl......
  • Global and United States In Vivo Imaging Systems Market Insights, Forecast to 2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 134
    In Vivo Imaging Systems market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global In Vivo Imaging Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the In Vivo Imaging Systems m......
  • Global and China Surface Plasmon Resonance (SPR) Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 98
    Global Surface Plasmon Resonance (SPR) Scope and Market Size Surface Plasmon Resonance (SPR) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Surface Plasmon Resonance (SPR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segmen......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs